[1]
“Assessing two strategies for production of murine ascites with anti-SARS-CoV-2 monoclonal antibodies”, Cluj Vet J, vol. 26, no. 3, pp. 2–7, Dec. 2021, doi: 10.52331/cvj.v26i3.31.